SCHEMBL6180796

SCHEMBL6180796

COc1cc2ncnc(Nc3ccc4c(c3)OCCO4)c2cc1OC

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 14/20 0.69
CLK1 P49759 1/20 0.69
ABCG2 Q9UNQ0 1/20 0.69
LCK P06239 7/20 0.67
SRC P12931 1/20 0.66
KDR P35968 6/20 0.64
RET P07949 5/20 0.63
KIF5B P33176 2/20 0.63
FLT1 P17948 1/20 0.62
GAK O14976 1/20 0.62
RIPK2 O43353 1/20 0.62
STK10 O94804 1/20 0.62
FLT3 P36888 1/20 0.62
JAK3 P52333 1/20 0.62
AAK1 Q2M2I8 1/20 0.62
Q6ZSR9 Q6ZSR9 1/20 0.62
SLK Q9H2G2 1/20 0.62
IRAK4 Q9NWZ3 1/20 0.62
RPS6KA6 Q9UK32 1/20 0.62
ALK Q9UM73 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6182470 0.99 EGFR (0.70) EGFRCLK1ABCG2LCKSRC
SCHEMBL5565334 0.93 SRC (0.71) EGFRCLK1ABCG2LCKSRC
SCHEMBL5650428 0.83 KDR (0.69) KDR
SCHEMBL5565137 0.82 EGFR (1.00) EGFRCLK1ABCG2LCKSRC
SCHEMBL18292487 0.81 MAPT (0.67) EGFRSRCPDE5A
SCHEMBL4378099 0.80 SRC (1.00) EGFRABCG2LCKSRCKDR
SCHEMBL12308055 0.80 PDE5A (0.81) EGFRLCKSRCKDRFLT1
SCHEMBL18292469 0.79 EGFR (0.68) EGFRALK
SCHEMBL18292491 0.79 MAPT (0.64) EGFRABCG2SRC
SCHEMBL5565204 0.79 KDR (0.79) EGFRCLK1ABCG2LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0871448-B1 ARYL AND HETEROARYL QUINAZOLINE COMPOUNDS WHICH INHIBIT CSF-1R RECEPTOR TYROSINE KINASE AVENTIS PHARMA INC (US) 2005-03-02 EP claimed
US-RE37650-E1 Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase AVENTIS PHARMACETICAL PRODUCTS, INC. 2002-04-09 US claimed